Bristol Erbitux Decision Will Follow Feb. 26 FDA Meeting

Bristol-Myers Squibb will decide whether to proceed with the Erbitux collaboration with ImClone after a Feb. 26 meeting with FDA

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet